Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer
UF investigators found that interferon-y (central to antitumor immunity) has multiple negative effects on cell types within the pancreatic cancer microenvironment.